Atossa Therapeutics
ATOS
ATOS
11 hedge funds and large institutions have $972K invested in Atossa Therapeutics in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Barclays
London,
United Kingdom
|
$0 |
| 2 |
2
Citigroup
New York
|
$0 |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$8K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $281K | 50,000 | +50,000 | New |
|
2
Goldman Sachs
New York
| $191K | 34,049 | +34,049 | New |
|
|
BFA
3
BlackRock Fund Advisors
San Francisco,
California
| $155K | 27,538 | +2,160 | +9% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $150K | 26,735 | +26,735 | New |
|
5
Jane Street
New York
| $128K | 22,792 | +22,792 | New |
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $33K | 5,925 | +5,925 | New |
|
|
FANJ
7
Financial Architects (New Jersey)
Marlton,
New Jersey
| $19K | 3,454 | +3,454 | New |
|
|
U
8
UBS
Zurich,
Switzerland
| $8K | 1,391 | -61 | -4% |
|
|
BFEC
9
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $4K | 782 | +782 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $2K | 424 | +424 | New |
|
|
MFS
11
MSI Financial Services
Springfield,
Massachusetts
| $1K | 200 | – | – |
|
|
12
Barclays
London,
United Kingdom
| – | – | -2,700 | Closed |
|
|
13
Citigroup
New York
| – | – | -159 | Closed |
|